Resource Use and Disease Course in Dementia (REDIC)
- Conditions
- Neurodegenerative DiseasesDementia
- Registration Number
- NCT01920100
- Lead Sponsor
- Sykehuset Innlandet HF
- Brief Summary
This project is based on a three-year program that aims to improve the knowledge of the socioeconomic consequences of dementia in Norway. By including patients with and without dementia in four different cohorts (from nursing homes, from memory clinics, home-dwelling persons with dementia and elderly persons without dementia), the project's aim is to describe the course of dementia, the economical cost of dementia and to look into possible risk factors for dementia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 696
- All patients examined at a memory clinic with mild cognitive impairment or mild dementia
- None
In-home care sample
Inclusion Criteria:
- Persons 70 years of age or older receiving in-home care from the municipality
Exclusion Criteria:
- None
Nursing-home sample
Inclusion Criteria:
- All persons admitted to the nursing home with an expected stay of more than four weeks.
- Participants should be 65 years or older, unless established dementia disease, in which case younger persons also will be included
Exclusion Criteria:
- Life expectancy of less than six weeks
Control sample
Inclusion Criteria:
- Persons 65 years or older without any sign of dementia
Exclusion Criteria:
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost of dementia 3 years The cost of dementia is assessed with the Resource Utilization in Dementia (RUD) (Wimo et al. 2009), for a period of three years for all the four cohorts. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
- Secondary Outcome Measures
Name Time Method The course of neuropsychiatric symptoms 3 years The course of neuropsychiatric symptoms (depression, anxiety, psychosis, aggression, apathy, and cognition, are assessed with standardized assessment Tools. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Quality of Life in persons admitted to nursing homes 3 years Quality of Life is assessed with standardized assessment Tools. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Organizational factors of the nursing homes At baseline Organizational factors of the nursing homes and variables associated with the staff of the nursing homes will be collected at baseline, and the data will be used to explore associations between nursing home characteristics and the course of the symptoms in the patients.
DNA polymorphism At baseline DNA samples are collected for the nursing home cohort, and they are assessed for genetic polymorphism previous associated with dementia. The results are used as covariates in the analyses of the course of the symptoms and to look for risk factors for dementia.
Prescription of medication 3 years Prescription of medication is recorded at baseline, and the amount of medication used is recorded throughout the study period. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Trial Locations
- Locations (3)
University of Bergen
🇳🇴Bergen, Norway
Senter for omsorgsforskning - Midt
🇳🇴Namsos, Norway
Innlandet Hospital Trust
🇳🇴Ottestad, Norway